Advertisement

Frailty in Chronic Kidney Disease Elderly Patients

  • Angela BenjumeaEmail author
  • José Ricardo Jauregui
Chapter

Abstract

Older adults (aged ≥ 65 years) comprise the largest segment of the CKD population, and impaired kidney function is linked with unsuccessful aging. Individuals across the spectrum of kidney disease have clinical features of the frailty phenotype, suggesting that frailty is not confined to old age among vulnerable populations. This manifests as a high prevalence of impaired physical performance, emergent geriatric syndromes, disability, and risk of death. Considering the multiple system involvement underlying the symptoms and deficits seen in CKD, especially in the more severe stages, the concept of frailty is a highly useful tool to identify older adults with kidney disease who are on the trajectory of vulnerability leading to decline and death.

Keywords

Frailty Chronic kidney disease Global assessment in geriatric 

References

  1. 1.
    Jones DM, Song X, Rockwood K. Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc. 2004;52:1929–33.CrossRefGoogle Scholar
  2. 2.
    Morley JE, Haren MT, Rolland Y, Kim MJ. Frailty. Med Clin N Am. 2006;90:837–47.CrossRefGoogle Scholar
  3. 3.
    Slaets JP. Vulnerability in the elderly: frailty. Med Clin N Am. 2006;90:593–601.CrossRefGoogle Scholar
  4. 4.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRefGoogle Scholar
  5. 5.
    Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55:780–91.CrossRefGoogle Scholar
  6. 6.
    Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA. 1995;273:1348–53.CrossRefGoogle Scholar
  7. 7.
    Fried LF, Katz R, Cushman M, Sarnak M, Shlipak MG, Kuller L, Newman AB. Change in cardiovascular risk factors with progression of kidney disease. Am J Nephrol. 2009;29:334–41.CrossRefGoogle Scholar
  8. 8.
    Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63:1121–9.CrossRefGoogle Scholar
  9. 9.
    Pope A, Tarlov A. Disability in America: toward a national agenda for prevention. Institute of Medicine (U.S.) Committee on a National Agenda for the Prevention of Disabilities. Washington, DC: National Academy Press; 1991.Google Scholar
  10. 10.
    Adams PF, Hendershot GE, Marano MA. Current estimates from the national health interview survey, United States, 1996, Vital and Health Statistics, Series 10, No. 200. Hyattsville: National Center for Health Statistics; 1999.Google Scholar
  11. 11.
    Newman AB, Gottdiener JS, Mcburnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP. Associations of subclinical cardiovascular disease with frailty. J Gerontol Med Sci. 2001;56A:M158–66.CrossRefGoogle Scholar
  12. 12.
    Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP, Cardiovascular Health Study. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162(20):2333–41.CrossRefGoogle Scholar
  13. 13.
    Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52:625–34.CrossRefGoogle Scholar
  14. 14.
    Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255–63.CrossRefGoogle Scholar
  15. 15.
    Bortz WM. A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci. 2002;57:M283–8.CrossRefGoogle Scholar
  16. 16.
    Anderson JE, Kraus J, Sturgeon D. Incidence, prevalence, and outcomes of end-stage renal disease patients placed in nursing homes. Am J Kidney Dis. 1993;21:619–27.CrossRefGoogle Scholar
  17. 17.
    Brogan DJ, Haber M, Kutner NG. Functional decline among older adults: comparing a chronic disease cohort and controls when mortality rates are markedly different. J Clin Epidemiol. 2000;53:847–51.CrossRefGoogle Scholar
  18. 18.
    Hailpern SM, Melamed ML, Cohen HW, Hostetter TH. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2007;18:2205–13.CrossRefGoogle Scholar
  19. 19.
    Kurella M, Ireland C, Hlatky MA, Shlipak MG, Yaffe K, Hulley SB, Chertow GM. Physical and sexual function in women with chronic kidney disease. Am J Kidney Dis. 2004;43:868–76.CrossRefGoogle Scholar
  20. 20.
    Kurella M, Mapes DL, Port FK, Chertow GM. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2006;21:2543–8.CrossRefGoogle Scholar
  21. 21.
    Kurella M, Yaffe K, Shlipak MG, Wenger NK, Chertow GM. Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis. 2005;45:66–76.CrossRefGoogle Scholar
  22. 22.
    Shlipak MG, Stehman-Breen C, Fried LF, Song X, Siscovick D, Fried LP, Psaty BM, Newman AB. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis. 2004;43(5):861–7.CrossRefGoogle Scholar
  23. 23.
    Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18:2960–7.CrossRefGoogle Scholar
  24. 24.
    Wilhelm-Leen ER, Hall YN, Tamura MK, Chertow GM. Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med. 2009;122(7):664–71.  https://doi.org/10.1016/j.amjmed.2009.01.026.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Van Loon IN. The relevance of geriatric impairments in patients starting dialysis: a systematic review. Clin J Am Soc Nephrol. 2016;11:1245–59.  https://doi.org/10.2215/CJN.06660615.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Aiello F, Dueñas EP, Musso CG. Senescent nephropathy: the new renal syndrome. Healthcare (Basel). 2017;5(4). pii: E81. doi: https://doi.org/10.3390/healthcare5040081.CrossRefGoogle Scholar
  27. 27.
    Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A, Newman AB, Women’s Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc. 2005;53:1321–30.CrossRefGoogle Scholar
  28. 28.
    Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015;47(11):1801–7.  https://doi.org/10.1007/s11255-015-1112-z.CrossRefPubMedGoogle Scholar
  29. 29.
    Arai Y, Takayama M, Gondo Y, Inagaki H, Yamamura K, Nakazawa S, Kojima T, Ebihara Y, Shimizu K, Masui Y, Kitagawa K, Takebayashi T, Hirose N. Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. J Gerontol A Biol Sci Med Sci. 2008;63:1209–18.CrossRefGoogle Scholar
  30. 30.
    Artz AS. Anemia and the frail elderly. Semin Hematol. 2008;45:261–6.CrossRefGoogle Scholar
  31. 31.
    Swidler MA, Uribarri J, Siu AL. Characterization of frailty in older adults with chronic kidney disease (CKD): correlations with biomarkers of inflammation. J Am Soc Nephrol. 2005;16:514a.CrossRefGoogle Scholar
  32. 32.
    Musso CG, Vilas M, de Quirós FG, Núñez JF. The importance of evaluating frailty and social-behavioral factors for managing drugs and dialysis prescription in elderly patients. Drug Res (Stuttg). 2016;66(4):223–4.  https://doi.org/10.1055/s-0035-1565127.CrossRefGoogle Scholar
  33. 33.
    Gill TM, Robison JT, Tinetti ME. Difficulty and dependence: two components of the disability continuum among community-living older persons. Ann Intern Med. 1998;128:96–101.CrossRefGoogle Scholar
  34. 34.
    Gill TM, Williams CS, Tinetti ME. Assessing risk for the onset of functional dependence among older adults: the role of physical performance. J Am Geriatr Soc. 1995;43:603–9.CrossRefGoogle Scholar
  35. 35.
    Delano BG, Suresh U, Feldman J, Schneider D, Friedman EA. Dismal rehabilitation in predominantly type II diabetics on dialysis in inner-city Brooklyn. Clin Nephrol. 2000;54:94–104.PubMedGoogle Scholar
  36. 36.
    Lowder GM, Perri NA, Friedman EA. Demographics, diabetes type, and degree of rehabilitation in diabetic patients on maintenance hemodialysis in Brooklyn. J Diabet Complicat. 1988;2:218–26.CrossRefGoogle Scholar
  37. 37.
    Julius M, Hawthorne VM, Carpentier-Alting P, Kneisley J, Wolfe RA, Port FK. Independence in activities of daily living for endstage renal disease patients: biomedical and demographic correlates. Am J Kidney Dis. 1989;13:61–9.CrossRefGoogle Scholar
  38. 38.
    Kutner NG, Brogan DJ. Assisted survival, aging, and rehabilitation needs: comparison of older dialysis patients and age-matched peers. Arch Phys Med Rehabil. 1992;73:309–15.CrossRefGoogle Scholar
  39. 39.
    De Oreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30:204–12.CrossRefGoogle Scholar
  40. 40.
    Ifudu O, Paul H, Mayers JD, Cohen LS, Brezsnyak WF, Herman AI, Avram MM, Friedman EA. Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis. 1994;23:394–400.CrossRefGoogle Scholar
  41. 41.
    Ifudu O, Mayers J, Matthew J, Tan CC, Cambridge A, Friedman EA. Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA. 1994;271:29–33.CrossRefGoogle Scholar
  42. 42.
    Leinau L, Murphy TE, Bradley E, Fried T. Relationship between conditions addressed by hemodialysis guidelines and non-ESRD-specific conditions affecting quality of life. Clin J Am Soc Nephrol. 2009;4:572–8.CrossRefGoogle Scholar
  43. 43.
    Cook WL, Jassal SV. Functional dependencies among the elderly on hemodialysis. Kidney Int. 2008;73:1289–95.CrossRefGoogle Scholar
  44. 44.
    Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.CrossRefGoogle Scholar
  45. 45.
    Gill TM, Allore HG, Hardy SE, Guo Z. The dynamic nature of mobility disability in older persons. J Am Geriatr Soc. 2006;54:248–54.CrossRefGoogle Scholar
  46. 46.
    Hardy SE, Dubin JA, Holford TR, Gill TM. Transitions between states of disability and independence among older persons. Am J Epidemiol. 2005;161:575–84.CrossRefGoogle Scholar
  47. 47.
    Lo D, Chiu E, Jassal SV. A prospective pilot study to measure changes in functional status associated with hospitalization in elderly dialysis-dependent patients. Am J Kidney Dis. 2008;52:956–61.CrossRefGoogle Scholar
  48. 48.
    Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J, Newman AB, Robbins J. Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2007;18:282–6.CrossRefGoogle Scholar
  49. 49.
    Gallagher JC, Rapuri PB, Smith LM. An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab. 2007;92:51–8.CrossRefGoogle Scholar
  50. 50.
    Gallagher JC, Rapuri P, Smith L. Falls are associated with decreased renal function and insufficient calcitriol production by the kidney. J Steroid Biochem Mol Biol. 2007;103:610–3.CrossRefGoogle Scholar
  51. 51.
    Dukas LC, Schacht E, Mazor Z, Stähelin HB. A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int. 2005;16:332–8.CrossRefGoogle Scholar
  52. 52.
    Cook WL, Tomlinson G, Donaldson M, Markowitz SN, Naglie G, Sobolev B, Jassal SV. Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol. 2006;1:1191–6.CrossRefGoogle Scholar
  53. 53.
    Desmet C, Beguin C, Swine C, Jadoul M, Université Catholique de Louvain Collaborative Group. Falls in hemodialysis patients: prospective study of incidence, risk factors, and complications. Am J Kidney Dis. 2005;45:148–53.CrossRefGoogle Scholar
  54. 54.
    Ray WA, Taylor JA, Brown AK, Gideon P, Hall K, Arbogast P, Meredith S. Prevention of fall-related injuries in long-term care: a randomized controlled trial of staff education. Arch Intern Med. 2005;165:2293–8.CrossRefGoogle Scholar
  55. 55.
    Li M, Tomlinson G, Naglie G, Cook WL, Jassal SV. Geriatric comorbidities, such as falls, confer an independent mortality risk to elderly dialysis patients. Nephrol Dial Transplant. 2008;23:1396–400.CrossRefGoogle Scholar
  56. 56.
    Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009;24:2446–52.CrossRefGoogle Scholar
  57. 57.
    Kurella M, Chertow GM, Fried LF, Cummings SR, Harris T, Simonsick E, Satterfield S, Ayonayon H, Yaffe KA. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2005;16:2127–33.CrossRefGoogle Scholar
  58. 58.
    Kurella Tamura M, Wadley V, Yaffe K, McClure LA, Howard G, Go R, Allman RM, Warnock DG, McClellan W. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008;52:227–34.CrossRefGoogle Scholar
  59. 59.
    Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67:216–23.CrossRefGoogle Scholar
  60. 60.
    Rakowski DA, Caillard S, Agodoa LY, Abbott KC. Dementia as a predictor of mortality in dialysis patients. Clin J Am Soc Nephrol. 2006;1:1000–5.CrossRefGoogle Scholar
  61. 61.
    Gottlieb D, Mildworf B, Rubinger D, Melamed E. The regional cerebral blood flow in patients under chronic hemodialytic treatment. J Cereb Blood Flow Metab. 1987;7:659–61.CrossRefGoogle Scholar
  62. 62.
    Hata R, Matsumoto M, Handa N, Terakawa H, Sugitani Y, Kamada T. Effects of hemodialysis on cerebral circulation evaluated by transcranial Doppler ultrasonography. Stroke. 1994;25:408–12.CrossRefGoogle Scholar
  63. 63.
    Ishida I, Hirakata H, Sugimori H, Omae T, Hirakata E, Ibayashi S, Kubo M, Fujishima M. Hemodialysis causes severe orthostatic reduction in cerebral blood flow velocity in diabetic patients. Am J Kidney Dis. 1999;34:1096–104.CrossRefGoogle Scholar
  64. 64.
    Arieff A. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int. 1994;45:629–35.CrossRefGoogle Scholar
  65. 65.
    Murray AM, Pederson SL, Tupper DE, Hochhalter AK, Miller WA, Li Q, Zaun D, Collins AJ, Kane R, Foley RN. Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. Am J Kidney Dis. 2007;50:270–8.CrossRefGoogle Scholar
  66. 66.
    Oreopoulos DG, Dimkovic N. Geriatric nephrology is coming of age. J Am Soc Nephrol. 2003;14:1099–101.CrossRefGoogle Scholar
  67. 67.
    Brown EA, Johansson L. Old age and frailty in the dialysis population. J Nephrol. 2010;23:502–7.PubMedGoogle Scholar
  68. 68.
    Cavalli A, Del Vecchio L, Locatelli F. Geriatric nephrology. J Nephrol. 2010;23(Suppl 15):S11–5.PubMedGoogle Scholar
  69. 69.
    US renal data system: USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, National Institute of Health, National Institute of Diabetes and Digestive And Kidney Disease; 2010.Google Scholar
  70. 70.
    Jassal SV, Chiu E, Li M. Geriatric hemodialysis rehabilitation care. Adv Chronic Kidney Dis. 2008;15:115–22.CrossRefGoogle Scholar
  71. 71.
    Kim JC, Kalantar-Zadeh K, Kopple J. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013;24:337–5.  https://doi.org/10.1681/ASN.2012010047.CrossRefPubMedGoogle Scholar
  72. 72.
    Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein energy-wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015;18(3):254–62.  https://doi.org/10.1097/MCO.0000000000000171.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Musso CG, Giordani MC, Imperiali N. Aging kidney transplantation. Rev Investig Clin. 2016;68(2):68–74.Google Scholar
  74. 74.
    Musso CG, Jauregui JR. How to differentiate renal senescence from chronic kidney disease in clinical practice. Postgrad Med. 2016;128(7):716–21.  https://doi.org/10.1080/00325481.2016.1209963.CrossRefGoogle Scholar
  75. 75.
    Stack AG, Murthy B. Exercise and limitations in physical activity levels among new dialysis patients in the United States: an epidemiologic study. Ann Epidemiol. 2008;18:880–8.CrossRefGoogle Scholar
  76. 76.
    Johansen KL, Chertow GM, Kutner NG, Dalrymple LS, Grimes BA, Kaysen GA. Low level of self-reported physical activity in ambulatory patients new to dialysis. Kidney Int. 2010;78:1164–70.CrossRefGoogle Scholar
  77. 77.
    Pupim LB, Heimbürger O, Qureshi AR, Ikizler TA, Stenvinkel P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 2005;68:2368–74.CrossRefGoogle Scholar
  78. 78.
    Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1–7.CrossRefGoogle Scholar
  79. 79.
    Johansen KL, Shubert T, Doyle J, Soher B, Sakkas GK, Kent-Braun JA, Muscle atrophy in patients receiving hemodialysis. Effects on muscle strength, muscle quality, and physical function. Kidney Int. 2003;63:291–7.CrossRefGoogle Scholar
  80. 80.
    Sterky E, Stegmayr BG. Elderly patients on haemodialysis have 50% less functional capacity than gender- and age-matched healthy subjects. Scand J Urol Nephrol. 2005;39:423–30.CrossRefGoogle Scholar
  81. 81.
    Brown E, Johansson L. Dialysis options for end-stage renal disease in older people. Nephron Clin Pract. 2011;119(Suppl 1):c10–3.  https://doi.org/10.1159/000328019.CrossRefPubMedGoogle Scholar
  82. 82.
    Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo controlled trial. Lancet. 2000;356:1213–8.CrossRefGoogle Scholar
  83. 83.
    Noble HR, Agus A, Brazil K, Burns A, Goodfellow NA, Guiney M, McCourt F, McDowell C, Normand C, Roderick P, Thompson C, Maxwell AP, Yaqoob MM. Palliative Care in chronic Kidney diSease: the PACKS study—quality of life, decisión making, costs and impact on carers in people managed without dialysis. BMC Nephrol. 2015;16:104.CrossRefGoogle Scholar
  84. 84.
    Tattersall J, Farrington K, Gentile G, Kooman J, Macias Núñez JF, Nistor I, Van Biesen W, Covic A, European Renal Best Practice Guidelines Group and the European Union of Geriatric Medicine Societies (EUGMS). Is Kt/V useful in elderly dialysis patients? Pro- and con arguments. Nephrol Dial Transplant. 2018;16:742–50.  https://doi.org/10.1093/ndt/gfy042.CrossRefGoogle Scholar
  85. 85.
    Musso CG, Schwartz P, Deira J, Macias Núñez JF. Is it correct to use a unique conventional dialysis prescription in the elderly? Four alternative schedules for dialyzing elderly patients. Int J Ren Dis Ther. in press.Google Scholar
  86. 86.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Chapter 3: management of progression and complications of CKD. Kidney Int Suppl. 2013;3(1):73–90.CrossRefGoogle Scholar
  87. 87.
    Guideline development group, Bilo H, Coentrão L, Couchoud C, Covic A, De Sutter J, Drechsler C, Gnudi L, Goldsmith D, Heaf J. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). Nephrol Dial Transplant. 2015;30(Suppl 2);1:ii1–ii142.Google Scholar
  88. 88.
    Musso CG, Trigka K, Dousdampanis P, Jauregui J. Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature. Int Urol Nephrol. 2015;47(4):647–54.  https://doi.org/10.1007/s11255-014-0886-8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Internal Medicine and GeriatricsUniversidad de CaldasManizalesColombia
  2. 2.Ageing Biology UnitHospital Italiano de Buenos AiresBuenos AiresArgentina

Personalised recommendations